Overview Request Sample Pages Request Customization Download PDF
You are viewing: South Korea Infusion Pump Market analysis
Part of: Infusion Pump Market (Global)

The South Korea Infusion Pump Market was valued at $151.2 Million in 2025 and projected to reach to $230.6 Million by 2030, representing a compound annual growth rate of 8.8%. South Korea's infusion pump market is positioned for sustained growth driven by demographic shifts and healthcare modernization.

South Korea Infusion Pump Market Trends and Insights

  • This 8.8% compound annual growth rate reflects South Korea's advanced healthcare infrastructure and increasing demand for precision drug delivery systems.
  • South Korea's aging population and rising prevalence of chronic diseases are driving adoption of infusion pump technologies across hospitals, clinics, and home care settings. The South Korea infusion pump market benefits from strong regulatory frameworks, high healthcare spending, and technological innovation in medical devices.
  • South Korea's manufacturers and healthcare providers are increasingly investing in smart infusion pumps with integrated safety features and connectivity capabilities.
  • Between 2025 and 2030, South Korea is expected to see accelerated market penetration driven by reimbursement improvements and growing awareness of infusion therapy benefits among healthcare professionals and patients..

Key Market Statistics

  • CAGR (2025-2030) 8.8% CAGR
  • Market Size, 2025 ~USD 151.2 Million
  • Forecast, 2030 ~USD 230.6 Million
  • Country South Korea

South Korea Infusion Pump Market Overview

Aging Population Driving Demand :

South Korea's rapidly aging demographic, with over 17% of the population aged 65+, is significantly increasing the prevalence of chronic diseases requiring infusion therapy, directly boosting market demand.

Advanced Healthcare Infrastructure :

South Korea's world-class healthcare system and high hospital automation rates create an ideal environment for adoption of sophisticated infusion pump technologies and digital health integration.

Strong CAGR Outpacing Global Average :

At 8.8% CAGR through 2030, South Korea's infusion pump market grows 1.4 percentage points faster than the global average of 7.4%, indicating accelerating regional adoption.

Market Expansion Trajectory :

The market is projected to grow from USD 151.2 million in 2025 to USD 230.6 million by 2030, representing a 52.5% increase in market value over five years.

South Korea Infusion Pump Market Dynamics

  • The country's aging population combined with increasing incidence of cancer, diabetes, and cardiovascular diseases creates strong demand for advanced drug delivery systems.
  • Government healthcare initiatives and reimbursement policies supporting precision medicine further accelerate market expansion. Technological innovation in smart infusion pumps with IoT connectivity and AI-enabled monitoring systems aligns with South Korea's digital health leadership.
  • Investment in hospital infrastructure upgrades and growing adoption of home-based infusion therapy present significant opportunities.
  • The competitive landscape will intensify as both domestic manufacturers and international players expand their presence in this high-growth market..

Related Ecosystem

Drug Delivery Devices

Top Technologies
  • Disposable Autoinjectors
  • Reusable Autoinjectors
  • Insulin Pumps
  • Pen Injectors
  • Transdermal Patches
Top Companies
  • Novo nordisk a/s
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Medtronic plc
  • Nipro Corporation

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • South Korea's infusion pump market is valued at USD 151.2 million in 2025 and will reach USD 230.6 million by 2030, representing an 8.8% CAGR.
      • South Korea's aging demographic and high prevalence of chronic diseases are primary growth catalysts for infusion pump adoption.
      • South Korea's advanced healthcare infrastructure and strong regulatory environment support rapid technology adoption and market expansion.
      • Smart infusion pumps with integrated safety and connectivity features are gaining traction in South Korea's healthcare facilities.

      Infusion Pump Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment SPECIALTY INFUSION PUMPS (Technology)
      Forecast Period 2025–2030
      Growth Rate CAGR of 7.4% from 2025 to 2030
      Largest Segment ACCESSORIES AND CONSUMABLES (Product)
      Market Size Base Year (Billions) ~USD 19.8 (2025)
      Revenue Forecast (Billions) ~USD 28.3 (2030)
      Segments Covered Product, Type, Technology, Mode, Mode Of Administration, End User, Application

      South Korea Infusion Pump Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Product

      • Accessories And Consumables
      • Devices

      By Type

      • Ambulatory Infusion Pump Dedicated Disposables
      • Ambulatory Infusion Pumps
      • Cannulas
      • Chemotherapy Pumps
      • Dedicated Accessories And Consumables
      • Disposable Infusion Pumps
      • Enteral Infusion Pump Dedicated Disposables
      • Enteral Infusion Pumps
      • Implantable Infusion Pump Dedicated Disposables
      • Implantable Infusion Pumps
      • Infusion Catheters
      • Insulin Infusion Pump Dedicated Disposables
      • Insulin Infusion Pumps
      • Iv/Administration Sets
      • Needless Connectors
      • Non-Dedicated Accessories And Consumables
      • Other Non-Dedicated Accessories And Consumables
      • Patient Controlled Analgesia Infusion Pumps
      • Pca Pump Dedicated Disposables
      • Syringe Infusion Pump Dedicated Disposables
      • Syringe Infusion Pumps
      • Tubing And Extension Sets
      • Valves
      • Volumetric Infusion Pumps
      • Volumetric Pump Dedicated Disposables

      By Technology

      • Specialty Infusion Pumps
      • Traditional Infusion Pumps

      By Mode

      • Portable Infusion Pumps
      • Stationary Infusion Pumps

      By Mode Of Administration

      • Enteral
      • Epidural
      • Intrathecal
      • Intravenous
      • Subcutaneous

      By End User

      • Academic & Research Institutes
      • Ambulatory Care Settings
      • Home Care Settings
      • Hospital
      • Hospitals
      • Oncology Centers
      • Other End Users

      By Application

      • Analgesia/Pain Management
      • Chemotherapy/ Oncology
      • Chemotherapy/Oncology
      • Diabetes Management
      • Gastroenterology
      • Hematology
      • Other Applications
      • Pediatrics / Neonatology
      • Pediatrics/ Neonatology
      • Pediatrics/Neonatology

      Target Audience

      • Medical Device Manufacturers : Evaluate South Korea's high-growth infusion pump market for product launches, partnerships, and market share expansion in a technologically advanced healthcare ecosystem.
      • Healthcare Investors & PE Firms : Assess investment opportunities in South Korea's 8.8% CAGR infusion pump sector, with clear market sizing and growth drivers for portfolio companies and acquisition targets.
      • Hospital & Healthcare Administrators : Understand procurement trends, technology adoption rates, and budget allocation patterns for infusion pump systems to optimize clinical operations and patient care delivery.
      • Market Research & Strategy Consultants : Access South Korea-specific market data and demographic insights to support client strategy development, competitive analysis, and market entry recommendations.
      • Pharmaceutical & Biotech Companies : Identify infusion therapy adoption trends and precision drug delivery opportunities in South Korea's growing chronic disease treatment market for product development planning.

      Key Companies in the South Korea Infusion Pump Market

      CompanyHQOwnershipStrongest segments
      NOVO NORDISK A/SDenmarkPublic CompanyDiabetes care (insulin, GLP-1 injectables, related therapies),Obesity therapies (injectable and oral GLP-1 for weight management),Rare Disease (rare blood and endocrine disorders, HRT),
      CONSORT MEDICALUnited KingdomPrivate CompanyInhalation devices (MDIs, DPIs, respiratory platforms),Injectable and autoinjector devices,Nasal and other specialty delivery devices,
      CONVATECUnited KingdomPublic CompanyAdvanced Wound Care,Ostomy Care,Continence and Critical Care,
      FRESENIUS SE & CO KGAAGermanyPublic CompanyInjectable generics & IV fluids,Clinical nutrition (enteral & parenteral),Biopharmaceuticals & biosimilars,
      HENRY SCHEINUnited StatesPublic CompanyGlobal Distribution and Value-Added Services,Global Specialty Products,Global Technology,
      PFIZERIndiaPublic CompanyInternal medicine (cardio, respiratory, gastro, neuroscience, women’s health, pain, nutrition),Vaccines,Anti-infectives and injectables,
      ZOLL MEDICAL CORPORATIONUnited StatesPrivate CompanyDefibrillators and monitors (hospital and EMS),Automated external defibrillators (public access and basic EMS),LifeVest and wearable defibrillation,
      WILO SEGermanyPrivate CompanyBuilding Services Residential,Building Services Commercial,Original Equipment Manufacturers (OEM),
      ANGIODYNAMICS, INCUnited StatesPublic CompanyMed Device – Peripheral Access and Drainage (angiographic catheters, guidewires, drainage catheters, micropuncture kits, ports),Med Tech – Thrombus Management (AlphaVac, AngioVac, thrombolytic catheters),Med Tech – Atherectomy (Auryon Atherectomy System),
      MALLINCKRODT PLCIrelandPrivate CompanyAutoimmune and rare disease therapies,Immunotherapy and neonatal respiratory critical care,Analgesics,
      BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (syringes, needles, vascular access, sharps, basic disposables),Connected Care (infusion therapy, IV medication safety, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
      BAXTER INTERNATIONAL, INC.United StatesPublic CompanyMedical Products & Therapies,Healthcare Systems & Technologies,Pharmaceuticals,
      MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
      ICU MEDICAL, INC.United StatesPublic CompanyInfusion pumps and medication safety software,Vascular access and needlefree connectors,IV solutions and diluents,
      TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
      NIPROJapanPublic CompanyDialysis products and services,Injection and infusion products, hospital and diabetic products,Pharmaceuticals (generic and kit products),
      AVANOS MEDICAL, INC.United StatesPublic CompanyDigestive health (Mic-Key, Corpak, NeoMed),Non-opioid surgical pain and recovery (ON-Q, ambIT, Game Ready),Interventional pain (COOLIEF, Trident, Esentec RFA),
      INSULET CORPORATIONUnited StatesPublic CompanyOmnipod 5 AID system,Omnipod DASH and legacy Omnipod systems,Drug-delivery pods (e.g., Neulasta Onpro),
      TANDEM DIABETES CARE, INC.United StatesPublic Companyt:slim X2 insulin pump systems,Tandem Mobi and automated insulin delivery systems,Cartridges and infusion sets,
      JMS CO., LTD.United StatesPublic CompanyU.S. Retail Coffee,U.S. Retail Frozen Handheld and Spreads,U.S. Retail Pet Foods,
      MOOG, INC.United StatesPublic CompanySpace and Defense,Military Aircraft,Commercial Aircraft,
      TELEFLEX INCORPORATEDUnited StatesPublic CompanyVascular access & emergency medicine (Arrow, EZ-IO, QuikClot),Interventional cardiology & peripheral (GuideLiner, Turnpike, MANTA, DCBs, stents),Surgical products (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),

      NOVO NORDISK A/S

      Novo Nordisk A/S is a Danish pharmaceutical company founded in 1923 with 67,900 employees. Operating as a public company, it is a major player in the global healthcare industry.

      CONSORT MEDICAL

      Consort Medical is a United Kingdom-based private company established in 1938 with 2,000 employees. The company operates in the medical device and pharmaceutical sectors.

      CONVATEC

      ConvaTec is a United Kingdom public company founded in 1978 specializing in medical devices and healthcare products. The company serves patients and healthcare providers globally.

      FRESENIUS SE & CO KGAA

      Fresenius SE & Co. KGaA is a German public company founded in 1912 with 177,783 employees. It is a leading global healthcare company providing dialysis, hospital care, and pharmaceutical products.

      HENRY SCHEIN

      Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a major distributor of healthcare products and services to dental, medical, and veterinary markets.

      PFIZER

      Pfizer India is a public company established in 1950 with 1,244 employees. The company operates as part of the global Pfizer pharmaceutical organization in the Indian market.

      ZOLL MEDICAL CORPORATION

      ZOLL Medical Corporation is a United States-based private company founded in 1980 with 1,908 employees. The company specializes in emergency medical devices and software solutions.

      WILO SE

      Wilo SE is a German private company founded in 1872 with 8,442 employees. The company is a leading manufacturer of pumps and pump systems for heating, cooling, and water management.

      ANGIODYNAMICS, INC

      AngioDynamics, Inc. is a United States-based public company founded in 1988 with 632 employees. The company develops and manufactures minimally invasive medical devices for vascular access and oncology.

      MALLINCKRODT PLC

      Mallinckrodt PLC is an Ireland-based private company founded in 1867 with 2,687 employees. The company operates in the specialty pharmaceutical and medical device sectors.

      BECTON, DICKINSON AND COMPANY

      Becton, Dickinson and Company is a United States public company founded in 1897 with 72,000 employees. It is a global medical technology company providing medical devices, laboratory equipment, and diagnostic products.

      BAXTER INTERNATIONAL, INC.

      Baxter International, Inc. is a United States-based public company founded in 1931 with 37,500 employees. The company develops and manufactures healthcare products including IV solutions, infusion systems, and renal care products.

      MEDTRONIC

      Medtronic is a public company headquartered in Ireland and founded in 1949 with 95,000 employees. It is a global leader in medical technology providing devices and therapies for chronic diseases.

      ICU MEDICAL, INC.

      ICU Medical, Inc. is a United States-based public company founded in 1984 with 13,000 employees. The company manufactures and distributes medical devices for critical care and oncology applications.

      TERUMO CORPORATION

      Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees. The company is a global medical device manufacturer specializing in cardiovascular, transfusion, and cellular therapy products.

      NIPRO

      Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures and distributes medical devices, pharmaceuticals, and healthcare products globally.

      AVANOS MEDICAL, INC.

      Avanos Medical, Inc. is a United States-based public company founded in 2014 with 2,287 employees. The company develops and markets medical devices for pain management and patient monitoring.

      INSULET CORPORATION

      Insulet Corporation is a United States public company founded in 2000 with 5,400 employees. The company manufactures and distributes insulin infusion pumps and continuous glucose monitoring systems.

      TANDEM DIABETES CARE, INC.

      Tandem Diabetes Care, Inc. is a United States-based public company founded in 2006 with 2,500 employees. The company develops and commercializes insulin delivery and diabetes management products.

      JMS CO., LTD.

      JMS Co., Ltd. is a United States-based public company founded in 1897 with 8,000 employees. The company operates in the medical device and healthcare products sector.

      MOOG, INC.

      Moog, Inc. is a United States-based public company founded in 1951 with 13,500 employees. The company manufactures precision motion and control products for aerospace, defense, and medical applications.

      TELEFLEX INCORPORATED

      Teleflex Incorporated is a United States public company founded in 1943 with 15,500 employees. The company designs and manufactures medical devices for critical care, surgery, and interventional procedures.

      Reasons to Buy this Report

      • Market-Specific Growth Insights : Understand South Korea's unique 8.8% CAGR trajectory and identify why this market outperforms global averages, enabling targeted investment and expansion strategies.
      • Demographic-Driven Opportunity Analysis : Access detailed analysis of South Korea's aging population impact on infusion pump demand, with quantified projections for chronic disease prevalence and treatment adoption rates.
      • Competitive Landscape Intelligence : Gain insights into South Korea's healthcare infrastructure advantages, regulatory environment, and competitive positioning of domestic versus international infusion pump manufacturers.
      • Revenue Forecasting & Valuation : Leverage precise market sizing (USD 151.2M in 2025 to USD 230.6M in 2030) for accurate financial modeling, investment decisions, and market entry planning specific to South Korea.
      • Technology Adoption Trends : Identify South Korea's digital health leadership and smart infusion pump adoption patterns, including IoT integration and AI-enabled monitoring system opportunities.

      Frequently asked questions

      What is the current size of South Korea's infusion pump market?

      South Korea's infusion pump market was valued at USD 151.2 million in 2025 and is expected to grow to USD 230.6 million by 2030.

      What is the projected growth rate for South Korea's infusion pump market?

      South Korea's infusion pump market is projected to grow at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2030.

      What factors are driving growth in South Korea's infusion pump market?

      Key drivers include South Korea's aging population, rising chronic disease prevalence, advanced healthcare infrastructure, strong regulatory frameworks, and increasing adoption of smart infusion pump technologies.

      Which segments are leading South Korea's infusion pump market?

      South Korea's market is driven by hospital and clinical settings, with growing adoption in home care environments and increasing demand for smart, connected infusion pump solutions.

      How does South Korea's infusion pump market compare to global trends?

      South Korea's 8.8% CAGR outpaces the global average of 7.4%, reflecting stronger healthcare investment, technological adoption, and demographic pressures in the region.

      RESEARCH METHODOLOGY

      This study extensively used both primary and secondary sources. The research involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

      Secondary Research

      This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the infusion pump market. It was also used to identify key players in the market and classify and segment the industry based on trends to the most detailed level. Additionally, significant developments related to market and technology perspectives were noted. A database of the primary industry leaders was also created using secondary research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the infusion pump market. Primary sources from the demand side include healthcare professionals from hospitals, nursing care facilities, long-term health centers, and ambulatory surgery centers.

      A breakdown of the primary respondents is provided below:

      Infusion Pump Market

      Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

      Note 2: Other designations include sales, marketing, and product managers.

      Note 3: Tiers are defined based on a company’s total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the infusion pump market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

      Infusion Pump Market

      Data Triangulation

      After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

      Market Definition

      The infusion pump encompasses the global spectrum of advanced medical devices designed to deliver precise volumes of fluids—ranging from medications and nutrients to various therapeutic solutions—directly into a patient's vascular system. These devices are integral to contemporary healthcare, ensuring a meticulous administration of treatments that demand consistent dosing regimens, such as chemotherapy, pain management, insulin therapy, and hydration protocols. Infusion pumps are engineered for high programmability and versatility, capable of delivering both micro and macro volumes at continuous or intermittent rates based on clinical requirements. They can be categorized by functionality into several types: volumetric pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, ambulatory infusion pumps, insulin pumps, and implantable infusion pumps. In contrast to traditional manual delivery methods, infusion pumps enhance accuracy, safety, and automation, making them indispensable in critical care environments and for effective chronic disease management. Their technological advancements facilitate complex infusion scenarios and improve patient outcomes through reliable dosing accuracy and reduced medication errors.

      Stakeholders

      • Medical device manufacturers and distributors
      • Infusion pump manufacturers
      • Infusion pump and related instrument manufacturing companies
      • Suppliers and distributors of infusion pumps
      • Hospitals and ambulatory surgery centers
      • Clinics
      • Home healthcare agencies
      • Research and consulting firms
      • Contract manufacturing organizations
      • Venture capitalists

      Report Objectives

      • To define, describe, segment, and forecast the infusion pump market by type, mode of administration, application, end user, and region
      • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall infusion pump market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the infusion pump market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the infusion pump market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

       

      Get the Full Infusion Pump Market Report

      Full forecast, segment splits, and company analysis for all Infusion Pump Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status